Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 4 records, 1 pages
Search For: Dendritic Cell Cancer Vaccine Immunotherapy
Global Dendritic Cell Cancer Vaccine Immunotherapy Supply, Demand and Key Producers, 2024-2030
29 Feb 2024
Pharma & Healthcare
Dendritic Cell Cancer Vaccine Immunotherapy
The global Dendritic Cell Cancer Vaccine Immunotherapy market size is expected to reach $ 1220.9 million by 2030, rising at a market growth of 9.7% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Dendritic Cell Cancer Vaccine Immunotherapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
04 Jan 2024
Pharma & Healthcare
Dendritic Cell Cancer Vaccine Immunotherapy
According to our (Global Info Research) latest study, the global Dendritic Cell Cancer Vaccine Immunotherapy market size was valued at USD 640 million in 2023 and is forecast to a readjusted size of USD 1220.9 million by 2030 with a CAGR of 9.7% during review period.
USD3480.00
Add To Cart
Global Dendritic Cell Cancer Vaccine Immunotherapy Supply, Demand and Key Producers, 2023-2029
23 Jan 2023
Pharma & Healthcare
Dendritic Cell Cancer Vaccine Immunotherapy
The global Dendritic Cell Cancer Vaccine Immunotherapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Global Dendritic Cell Cancer Vaccine Immunotherapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029
10 Jan 2023
Pharma & Healthcare
Dendritic Cell Cancer Vaccine Immunotherapy
Dendritic cells (DCs) are one of the major antigen-presenting cells found in lymphoid organs. Main function of the dendritic cells is antigen display and activation of T-cells. Antigen display presents the identity of pathogen to T-cells for their identification and elimination from the body. These cells have proficiency of capturing and processing tumor antigens, which activates expression of lymphocyte co-stimulatory molecules. Consequently, it results in secretion of cytokines to initiate immune response. Over 60 dendritic cell and tumor cell cancer vaccines are currently in clinical / preclinical stages of development; 70% of the pipeline comprises of dendritic cell cancer vaccines.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Dendritic Cell Cancer Vaccine Immunotherapy
Total: 4 records, 1 pages
The global Dendritic Cell Cancer Vaccine Immunotherapy market size is expected to reach $ 1220.9 million by 2030, rising at a market growth of 9.7% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Dendritic Cell Cancer Vaccine Immunotherapy market size was valued at USD 640 million in 2023 and is forecast to a readjusted size of USD 1220.9 million by 2030 with a CAGR of 9.7% during review period.
USD3480.00
Add To Cart
The global Dendritic Cell Cancer Vaccine Immunotherapy market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Dendritic cells (DCs) are one of the major antigen-presenting cells found in lymphoid organs. Main function of the dendritic cells is antigen display and activation of T-cells. Antigen display presents the identity of pathogen to T-cells for their identification and elimination from the body. These cells have proficiency of capturing and processing tumor antigens, which activates expression of lymphocyte co-stimulatory molecules. Consequently, it results in secretion of cytokines to initiate immune response. Over 60 dendritic cell and tumor cell cancer vaccines are currently in clinical / preclinical stages of development; 70% of the pipeline comprises of dendritic cell cancer vaccines.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>